H. Wildiers MD, PhD, H. Denys MD, PhD, C. Fontaine MD, A. Awada MD, PhD
Knowledge on adjuvant and neoadjuvant chemotherapy regimens in breast cancer is increasing rapidly. Many different regimens are available: some have been compared with each other, but still many questions remain to be answered. At the breast cancer task force meeting of the Belgian Society of Medical Oncology (BSMO) in Brussels, on February 21st 2014, 41 medical oncologists involved in breast cancer management reviewed the most important recent data. The task force discussed a framework for regimen selection in clinical practice. The authors of this paper summarised the literature and meeting discussion, highlighting controversial areas.
A. Awada MD, PhD, L. Annemans , D. Broeckx PharmD, P. Pauwels MD, PhD, S. Simoens , S. Van Belle MD, PhD, E. van Cutsem MD, PhD, E. Van Hoof PhD, MSc, J. De Grève MD, PhD
Top
